HIRA intensively to review combo medication with NSAIDs.

Published: 2005-07-20 06:56:00

Updated: 2005-07-20 06:56:00

The Health Insurance Review AGency (HIRA) has approved the medication propriety review plan through the Central Review Commission as one of the 2005 NHI payment review programs.

This year review works seemed to focus on the NSAIDs (non-steroidal anti-inflammatory drugs) and an oral and systemi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK